Pasithea Total Revenue vs Depreciation And Amortization Analysis

KTTAW Stock  USD 0.03  0.00  0.00%   
Pasithea Therapeutics financial indicator trend analysis is much more than just breaking down Pasithea Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pasithea Therapeutics is a good investment. Please check the relationship between Pasithea Therapeutics Total Revenue and its Depreciation And Amortization accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Revenue vs Depreciation And Amortization

Total Revenue vs Depreciation And Amortization Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pasithea Therapeutics Total Revenue account and Depreciation And Amortization. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pasithea Therapeutics' Total Revenue and Depreciation And Amortization is 0.7. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Pasithea Therapeutics Corp, assuming nothing else is changed. The correlation between historical values of Pasithea Therapeutics' Total Revenue and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Pasithea Therapeutics Corp are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Total Revenue i.e., Pasithea Therapeutics' Total Revenue and Depreciation And Amortization go up and down completely randomly.

Correlation Coefficient

0.7
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Revenue

Total revenue comprises all receipts Pasithea Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.
Most indicators from Pasithea Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pasithea Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At this time, Pasithea Therapeutics' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 31 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 16.32 in 2024.
 2021 2022 2023 2024 (projected)
Other Operating Expenses4.5M15.3M16.0M9.9M
Depreciation And Amortization1.4K5.1K648.5K680.9K

Pasithea Therapeutics fundamental ratios Correlations

0.530.71.0-0.96-0.630.680.980.980.940.860.950.911.00.99-0.250.98-0.25-0.420.6-0.42-0.42-0.42-0.42-0.41-0.41
0.530.80.52-0.35-0.940.940.460.460.740.470.70.730.520.46-0.950.43-0.95-0.990.18-0.99-0.99-0.99-0.99-0.98-0.88
0.70.80.68-0.54-0.940.920.570.570.90.80.890.930.680.58-0.660.55-0.66-0.770.66-0.76-0.74-0.76-0.77-0.79-0.53
1.00.520.68-0.97-0.610.670.990.990.930.850.940.91.00.99-0.230.98-0.23-0.40.59-0.4-0.41-0.4-0.4-0.39-0.4
-0.96-0.35-0.54-0.970.42-0.48-0.99-0.99-0.83-0.74-0.86-0.8-0.97-0.980.05-0.990.050.22-0.480.220.220.220.220.220.2
-0.63-0.94-0.94-0.610.42-1.0-0.51-0.51-0.85-0.7-0.81-0.86-0.61-0.520.85-0.480.850.92-0.510.920.910.920.920.920.79
0.680.940.920.67-0.48-1.00.580.580.880.730.840.880.670.58-0.830.55-0.83-0.910.5-0.91-0.91-0.91-0.91-0.9-0.81
0.980.460.570.99-0.99-0.510.581.00.870.770.890.830.991.0-0.161.0-0.16-0.330.48-0.33-0.34-0.33-0.33-0.31-0.36
0.980.460.570.99-0.99-0.510.581.00.870.770.890.830.991.0-0.161.0-0.16-0.330.48-0.33-0.34-0.33-0.33-0.31-0.36
0.940.740.90.93-0.83-0.850.880.870.870.91.00.990.930.88-0.50.86-0.5-0.650.66-0.65-0.65-0.65-0.65-0.65-0.56
0.860.470.80.85-0.74-0.70.730.770.770.90.890.90.850.78-0.220.76-0.22-0.380.91-0.38-0.39-0.38-0.38-0.37-0.37
0.950.70.890.94-0.86-0.810.840.890.891.00.890.990.940.89-0.460.87-0.46-0.610.65-0.61-0.6-0.61-0.61-0.62-0.5
0.910.730.930.9-0.8-0.860.880.830.830.990.90.990.90.84-0.50.81-0.5-0.660.68-0.65-0.64-0.65-0.66-0.66-0.51
1.00.520.681.0-0.97-0.610.670.990.990.930.850.940.90.99-0.230.98-0.23-0.40.59-0.4-0.41-0.4-0.4-0.39-0.4
0.990.460.580.99-0.98-0.520.581.01.00.880.780.890.840.99-0.161.0-0.16-0.330.49-0.33-0.34-0.33-0.33-0.32-0.36
-0.25-0.95-0.66-0.230.050.85-0.83-0.16-0.16-0.5-0.22-0.46-0.5-0.23-0.16-0.131.00.980.010.980.980.980.980.980.86
0.980.430.550.98-0.99-0.480.551.01.00.860.760.870.810.981.0-0.13-0.13-0.30.47-0.3-0.31-0.3-0.3-0.28-0.34
-0.25-0.95-0.66-0.230.050.85-0.83-0.16-0.16-0.5-0.22-0.46-0.5-0.23-0.161.0-0.130.980.010.980.980.980.980.980.86
-0.42-0.99-0.77-0.40.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.66-0.4-0.330.98-0.30.98-0.131.01.01.01.01.00.86
0.60.180.660.59-0.48-0.510.50.480.480.660.910.650.680.590.490.010.470.01-0.13-0.13-0.13-0.13-0.13-0.13-0.11
-0.42-0.99-0.76-0.40.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.65-0.4-0.330.98-0.30.981.0-0.131.01.01.00.990.88
-0.42-0.99-0.74-0.410.220.91-0.91-0.34-0.34-0.65-0.39-0.6-0.64-0.41-0.340.98-0.310.981.0-0.131.01.01.00.980.91
-0.42-0.99-0.76-0.40.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.65-0.4-0.330.98-0.30.981.0-0.131.01.01.00.990.88
-0.42-0.99-0.77-0.40.220.92-0.91-0.33-0.33-0.65-0.38-0.61-0.66-0.4-0.330.98-0.30.981.0-0.131.01.01.01.00.86
-0.41-0.98-0.79-0.390.220.92-0.9-0.31-0.31-0.65-0.37-0.62-0.66-0.39-0.320.98-0.280.981.0-0.130.990.980.991.00.82
-0.41-0.88-0.53-0.40.20.79-0.81-0.36-0.36-0.56-0.37-0.5-0.51-0.4-0.360.86-0.340.860.86-0.110.880.910.880.860.82
Click cells to compare fundamentals

Pasithea Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.